Improved healing potential, backed by science
Safer and simpler for superior patients experiences
Efficient and cost-effective treatments
Bone graft products should make life better for patients.
Are you using the best tools for the job?
Upgrade to the latest in bone regeneration technology
Give your surgeons stem cell technology that gets the job done
Partner with a company who puts your success first
Improve healing with immediate-acting bone regeneration technology1-5
Stem cell harvesting ought to be simple and efficient
Upgrade to synthetics that provide better handling and healing
Advanced synthetic technology is the new industry standard
TrelCor bone grafts consistently deliver for your patients
Cutting-edge stem cell technology, without the risks6
TrelCor sets the standard for healing potential.
Our advanced bone graft technology leads to consistent, successful results.
Nanocrystalline structure stimulates cellular healing on contact1-3
Bone-like surface chemistry jumpstarts the healing process4,5
Densely packed with robust granules for maximum bone contact
Our mission is to make it easier for surgeons and hospitals to provide better care — and improved outcomes — to their patients.
Musculoskeletal pain and injuries can bring a patient’s life to a screeching halt. Activities that once were simple can become physically impossible, and without proper treatment may only get worse. Biogennix believes in the restorative power of advanced bone regeneration materials.
That’s why our technologies exist: to provide surgeons with the best tools to treat musculoskeletal issues and improve patients’ lives.
• Our next-generation TrelCor Technology jumpstarts bone growth by stimulating cellular healing.
• Agilon Moldable delivers best-in-class handling while leveraging TrelCor’s advanced healing properties.
• The all-in-one DirectCell System brings simplicity and efficiency to Gold-Standard autologous cell harvesting and puts live cells in direct contact with cell-stimulating bone graft to boost healing.
Everything we develop is designed to improve lives and restore patients back to health faster.
By putting the most advanced tools in surgeons’ hands, Biogennix aims to help patients recover more quickly, easily, and completely.
TrelCor combines four cutting-edge advancements into one next-generation material, raising the bar for synthetic technology.
More than 50,000 use cases testify to TrelCor’s healing power.
Easy to work with and capable of boosting patients’ natural healing abilities, Agilon advanced synthetics are densely packed with bioactive7 granules.
Thanks to superior handling and cell-stimulating technology, Agilon can be implanted with complete confidence.
The DirectCell System ensures you harvest more stem cells, eliminates the need to centrifuge, extracts high-quality autograft rich with marrow, and elevates your patient outcomes.
It’s the powerful all-in-one bone grafting solution that works as hard as you do.
TrelCor combines four cutting-edge advancements into one next-generation material, raising the bar for synthetic technology.
More than 50,000 use cases testify to TrelCor’s healing power.
Easy to work with and capable of boosting patients’ natural healing abilities, Agilon advanced synthetics are densely packed with bioactive7 granules.
Thanks to superior handling and cell-stimulating technology, Agilon can be implanted with complete confidence.
The DirectCell System ensures you harvest more stem cells, eliminates the need to centrifuge, extracts high-quality autograft rich with marrow, and elevates your patient outcomes.
It’s the powerful all-in-one bone grafting solution that works as hard as you do.
References 1. Zhang J. et al. J. of Tissue Eng. And Regen. Med. 11: pp. 3273 – 3283 (2017); 2. Duan R. et al.ACS Biomater. Sci. Eng. 4: pp. 3347 – 3355 (2018); 3.Data on File: Ectopic Bone Formation Response of TrelCor in a Sheep Intramuscular Pouch Model; 4. Spence G. et al. Key Eng. Materials Vols. 309-31: pp 207-210 (2006); 5. Hayashi K. et al. Materials Today Bio. 4: pp. 1-11 (2019); 6. Use of autologous stem cells eliminates the risk of disease transmission that is associated with cellular allograft product. 7. Data on File: Evaluation of the Bioactive Response to TrelCor Bone Graft Products.
